Blockchain Registration Transaction Record

BioCorRx Appoints Former White House Drug Policy Director to Advisory Board

BioCorRx appoints Richard J. Baum, former Acting Director of White House ONDCP, to Strategic Advisory Board to advance addiction treatment and policy strategies.

This news matters because it signals a strengthening bridge between federal drug policy expertise and innovative addiction treatment development. Richard J. Baum’s deep experience across six presidential administrations will help BioCorRx navigate complex regulatory and public health systems, potentially accelerating access to new therapies like LUCEMYRA® and BICX104. With millions of Americans affected by opioid and methamphetamine use disorders, and limited treatment options for methamphetamine use disorder, BioCorRx’s work—guided by Baum’s strategic counsel—could lead to more effective, evidence-based solutions and improved long-term recovery outcomes.